Atopic dermatitis is a medical condition with active clinical research programs worldwide.

45 total trials for this combination

Showing top 10 of 45 trials

Trials

NCT ID	Title	Status	Phase
NCT03587805	Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND	COMPLETED	PHASE3
NCT00475605	A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis	TERMINATED	—
NCT06389136	A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab	RECRUITING	—
NCT05882877	A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)	ACTIVE_NOT_RECRUITING	PHASE3
NCT04392154	Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)	COMPLETED	PHASE3
NCT01949311	Open-label Study of Dupilumab in Patients With Atopic Dermatitis	COMPLETED	PHASE3
NCT05704738	A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)	COMPLETED	PHASE3
NCT02743871	Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis	COMPLETED	PHASE1
NCT05601882	A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis	COMPLETED	PHASE3
NCT03568318	A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis	ACTIVE_NOT_RECRUITING	PHASE3

Related Pages

All Atopic dermatitis trials All trials in Tulsa, United States